Factors associated with children's health facility visits for primaquine treatment in rural Papua New Guinea

To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they pr...

Full description

Saved in:
Bibliographic Details
Published inMalaria journal Vol. 18; no. 1; p. 42
Main Authors Yoshii, Akiko, Sekihara, Makoto, Furusawa, Takuro, Hombhanje, Francis, Tsukahara, Takahiro
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 20.02.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment.
AbstractList To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment.
To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment.
Abstract Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. Methods A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Results Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Conclusions Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment.
Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. Methods A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Results Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Conclusions Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment. Keywords: Antimalarials, Therapeutic uses, Child, Vivax malaria, Continuity of patient care, Health service accessibility, Patient compliance, Patient acceptance of health care, Appointments and schedules
Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective. Methods A community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria. Results Of 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF. Conclusions Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment.
BACKGROUNDTo control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in many malaria-endemic countries, village health volunteers (VHVs) are engaged in diagnostic treatment of malaria in remote communities, they principally provide blood-stage treatment. In such a situation, access to PQ following blood-stage treatment can be a barrier to complete treatment. However, studies on access to PQ treatment have been scarce and limited in health facility-based settings. This study aimed to identify factors associated with access to PQ treatment in rural Papua New Guinea (PNG) from the community case management perspective.METHODSA community-based, cross-sectional survey was conducted to collect sociodemographic information on children under 15 years of age, their households, and their caretakers in East Sepik Province, PNG. Data collection lasted from February to March, 2015. Information on the diagnoses of potential non-falciparum malaria and prescription of PQ in preceding year (January to December 2014) were obtained from child health-record books. Then, multilevel logistic regression model was used to determine the factors associated with formal health facility visits for PQ treatment among children with potential non-falciparum malaria.RESULTSOf 420 episodes diagnosed as potential non-falciparum malaria, 46 (11%) were immediately given PQ. The rest were instructed to visit formal health facilities (HFs) for PQ, and the patients obtained PQ during the second visit to HFs was 44%. Consequently, the overall proportion of PQ prescription was 50%. Logistic regression analysis suggested that among the patients who were instructed to visit HFs for PQ treatment, the initial visit to VHV and higher transportation costs to HF were inversely associated with PQ prescription during the second visit to an HF.CONCLUSIONSFew children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria. These findings suggest a need to establish a policy to reduce structural and economic barriers and improve rural inhabitant access to PQ treatment.
ArticleNumber 42
Audience Academic
Author Furusawa, Takuro
Yoshii, Akiko
Tsukahara, Takahiro
Sekihara, Makoto
Hombhanje, Francis
Author_xml – sequence: 1
  givenname: Akiko
  surname: Yoshii
  fullname: Yoshii, Akiko
  organization: Department of International Affairs and Tropical Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan
– sequence: 2
  givenname: Makoto
  surname: Sekihara
  fullname: Sekihara, Makoto
  organization: Department of Tropical Medicine and Parasitology, Juntendo University School of Medicine, 6th Floor, Bldg. No.9, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan
– sequence: 3
  givenname: Takuro
  surname: Furusawa
  fullname: Furusawa, Takuro
  organization: Department of Ecology and Environment, Graduate School of Asian and African Area Studies, Kyoto University, Room#AA431, Research Bldg. No.2, Yoshida-Honmachi, Sakyo-ku, Kyoto, 606-8501, Japan
– sequence: 4
  givenname: Francis
  surname: Hombhanje
  fullname: Hombhanje, Francis
  organization: Centre for Health Research and Diagnostics, Divine Word University-Rabaul Campus, Kokopo, Papua New Guinea
– sequence: 5
  givenname: Takahiro
  orcidid: 0000-0002-4086-794X
  surname: Tsukahara
  fullname: Tsukahara, Takahiro
  email: tsukahara.takahiro@twmu.ac.jp, tsukahara.takahiro@twmu.ac.jp
  organization: School of Economics, Hosei University Graduate School, 2-15-2 Ichigaya Tamachi, Shinjuku-ku, Tokyo, 162-0843, Japan. tsukahara.takahiro@twmu.ac.jp
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30786891$$D View this record in MEDLINE/PubMed
BookMark eNptUk1v1DAUjFAR_YAfwAVZ4gCXFH_HuSBVFS2VKuAAZ-vFsXe9SuKt7bTqv8fpltJFyAc_jeeN3zzNcXUwhclW1VuCTwlR8lMitGWyxqStqWxEzV9UR4SXgqpGHDyrD6vjlDYYk0Y19FV1yHCjpGrJUTVcgMkhJgQpBeMh2x7d-bxGZu2HPtrpQ0JrC0NBHBg_-HyPbn3yOSEXItpGP8LN7CeLcrSQRztl5CcU5wgD-gHbGdA3e4cuFwq8rl46GJJ983ifVL8uvvw8_1pff7-8Oj-7ro2QONeUU4Ubh3tsjGgZUIKLPScEVT2VrOu6RlGnLDguZYsJw50ThAPmYBRRnJ1UVzvdPsBGP8wY73UArx-AEFcaYvZmsLq30ANpDesw4YTzrm-lbIwkHXe8FU3R-rzT2s7daHtTDBZre6L7L5Nf61W41ZIpRhtRBD4-CsRwM9uU9eiTscMAkw1z0rRMLJgQChfq-3-omzDHqayqsFrGKZeM_2WtoBjwkwvlX7OI6jOhCGsxF7SwTv_DKqe3ozclR84XfK-B7BpMDClF6548EqyXuOld3HSJm17ippdR3j1fzlPHn3yx3-iu0NY
CitedBy_id crossref_primary_10_1186_s12889_021_11602_1
Cites_doi 10.1056/NEJMoa0804915
10.1016/S0277-9536(01)00036-3
10.1186/1475-2875-11-63
10.1016/j.ijpara.2016.06.006
10.3389/fpubh.2015.00275
10.1093/trstmh/try003
10.1371/journal.pone.0009047
10.1371/journal.pntd.0006230
10.1186/1475-2875-13-488
10.1186/s41182-016-0008-7
10.1093/heapol/czl029
10.4269/ajtmh.2007.77.947
10.1186/1475-2875-9-308
10.1093/ije/dys037
10.3329/jhpn.v27i1.3313
10.1186/1475-2875-9-347
10.1186/1475-2875-7-75
10.1186/1475-2875-8-41
10.1186/1475-2875-10-355
10.1046/j.1365-3156.2003.01030.x
10.1186/1475-2875-12-433
10.1007/s10461-009-9533-2
10.1097/QAI.0000000000000315
10.1371/journal.pone.0040183
10.1186/1471-2458-9-85
10.1590/0037-8682-0275-2015
10.2149/tmh.2008-13
10.1371/journal.pone.0000121
10.4269/ajtmh.2010.09-0521
10.1186/1475-2875-14-1
10.1186/s12936-017-1784-1
10.1186/1475-2875-8-118
10.1186/1475-2875-9-320
10.1093/infdis/80.3.237
10.1186/s12936-016-1588-8
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2019
DBID NPM
AAYXX
CITATION
3V.
7SS
7U9
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
F1W
FYUFA
GHDGH
H94
H95
H97
K9.
L.G
M0S
M1P
M7N
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12936-019-2675-4
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Entomology Abstracts (Full archive)
Virology and AIDS Abstracts
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database (Proquest)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
ASFA: Aquatic Sciences and Fisheries Abstracts
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
ProQuest Health & Medical Complete (Alumni)
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Aquatic Science & Fisheries Abstracts (ASFA) Professional
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Central China
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ASFA: Aquatic Sciences and Fisheries Abstracts
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed


Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Economics
EISSN 1475-2875
EndPage 42
ExternalDocumentID oai_doaj_org_article_deada19c3b014144bd9667c61b4f4957
A581390452
10_1186_s12936_019_2675_4
30786891
Genre Journal Article
GeographicLocations Papua New Guinea
Asia
Africa
GeographicLocations_xml – name: Papua New Guinea
– name: Africa
– name: Asia
GrantInformation_xml – fundername: JSPS KAKENHI
  grantid: JP25305023
– fundername: ;
  grantid: JP25305023
– fundername: ;
GroupedDBID ---
-A0
0R~
29M
2WC
3V.
53G
5VS
7X7
88E
8C1
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECGQY
EJD
EMB
EMK
EMOBN
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
AFPKN
CITATION
ABVAZ
AFGXO
AFNRJ
7SS
7U9
7XB
8FK
AZQEC
C1K
DWQXO
F1W
H94
H95
H97
K9.
L.G
M7N
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c560t-242807f0d0cc593a210267f5528d263bbb782f8eaf46690130bf514a04ac81843
IEDL.DBID RPM
ISSN 1475-2875
IngestDate Tue Oct 22 15:14:25 EDT 2024
Tue Sep 17 21:18:04 EDT 2024
Fri Oct 25 11:32:22 EDT 2024
Thu Oct 10 17:48:29 EDT 2024
Fri Feb 23 00:11:15 EST 2024
Fri Feb 02 04:29:06 EST 2024
Thu Sep 12 19:25:07 EDT 2024
Wed Oct 16 00:50:52 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Continuity of patient care
Health service accessibility
Patient acceptance of health care
Antimalarials
Therapeutic uses
Appointments and schedules
Child
Patient compliance
Vivax malaria
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-242807f0d0cc593a210267f5528d263bbb782f8eaf46690130bf514a04ac81843
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-4086-794X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383275/
PMID 30786891
PQID 2193424634
PQPubID 42600
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_deada19c3b014144bd9667c61b4f4957
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6383275
proquest_miscellaneous_2184535580
proquest_journals_2193424634
gale_infotracmisc_A581390452
gale_infotracacademiconefile_A581390452
crossref_primary_10_1186_s12936_019_2675_4
pubmed_primary_30786891
PublicationCentury 2000
PublicationDate 2019-02-20
PublicationDateYYYYMMDD 2019-02-20
PublicationDate_xml – month: 02
  year: 2019
  text: 2019-02-20
  day: 20
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Malaria journal
PublicationTitleAlternate Malar J
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References Y Inoue (2675_CR28) 2017; 111
U Haque (2675_CR9) 2012; 11
N Khantikul (2675_CR8) 2009; 27
J Recht (2675_CR47) 2018; 12
A Getahun (2675_CR42) 2010; 9
V Phommanivong (2675_CR14) 2010; 9
LK Das (2675_CR18) 2008; 7
DM Tuller (2675_CR44) 2010; 14
B Genton (2675_CR29) 2005; 48
R Takeuchi (2675_CR5) 2010; 9
A Souares (2675_CR6) 2009; 8
J Marfurt (2675_CR30) 2007; 77
N Hung (2675_CR45) 2008; 36
T Tsukahara (2675_CR15) 2015; 3
Papua New Guinea National Department of Health (2675_CR33) 2003
M Karyana (2675_CR23) 2016; 15
TN Nissen (2675_CR48) 2012; 7
R Zachariah (2675_CR49) 2006; 1
S Vyas (2675_CR37) 2006; 21
WHO (2675_CR35) 2015
KP Grietens (2675_CR22) 2010; 82
HE Ashwell (2675_CR27) 2009; 9
2675_CR19
WHO (2675_CR2) 2017
T Tanahashi (2675_CR53) 1978; 56
2675_CR13
D O'Keefe (2675_CR26) 2011; 54
2675_CR12
2675_CR11
CM Whorton (2675_CR50) 1947; 80
2675_CR10
2675_CR51
J Pulford (2675_CR24) 2013; 12
Divine Word University (2675_CR34) 2010
E Lin (2675_CR21) 2010; 5
MM Thandar (2675_CR41) 2015; 14
P Yenchitsomanus (2675_CR46) 1986; 29
ED Almeida (2675_CR7) 2016; 49
Papua New Guinea National Department of Health (2675_CR32) 2009
HA Karunajeewa (2675_CR31) 2008; 359
RJ Ingram (2675_CR52) 2014; 13
WHO (2675_CR1) 2015
EA Pereira (2675_CR38) 2011; 10
EL Matsumoto-Takahashi (2675_CR16) 2016; 44
O Müller (2675_CR40) 2003; 8
M Morrow (2675_CR17) 2009; 9
K Thriemer (2675_CR4) 2017; 16
2675_CR25
JK Baird (2675_CR3) 2017; 47
IK Nyamongo (2675_CR39) 2002; 54
I Mueller (2675_CR20) 2009; 8
LA Sowah (2675_CR43) 2014; 67
LD Howe (2675_CR36) 2012; 41
References_xml – volume: 359
  start-page: 2545
  year: 2008
  ident: 2675_CR31
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0804915
  contributor:
    fullname: HA Karunajeewa
– volume-title: Guidelines for the treatment of malaria
  year: 2015
  ident: 2675_CR35
  contributor:
    fullname: WHO
– volume: 54
  start-page: 377
  year: 2002
  ident: 2675_CR39
  publication-title: Soc Sci Med
  doi: 10.1016/S0277-9536(01)00036-3
  contributor:
    fullname: IK Nyamongo
– volume: 29
  start-page: 53
  year: 1986
  ident: 2675_CR46
  publication-title: P N G Med J
  contributor:
    fullname: P Yenchitsomanus
– ident: 2675_CR51
– volume: 11
  start-page: 63
  year: 2012
  ident: 2675_CR9
  publication-title: Malar J
  doi: 10.1186/1475-2875-11-63
  contributor:
    fullname: U Haque
– ident: 2675_CR13
– volume: 47
  start-page: 371
  year: 2017
  ident: 2675_CR3
  publication-title: Int J Parasitol
  doi: 10.1016/j.ijpara.2016.06.006
  contributor:
    fullname: JK Baird
– volume: 3
  start-page: 275
  year: 2015
  ident: 2675_CR15
  publication-title: Front Public Health.
  doi: 10.3389/fpubh.2015.00275
  contributor:
    fullname: T Tsukahara
– volume: 111
  start-page: 490
  year: 2017
  ident: 2675_CR28
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1093/trstmh/try003
  contributor:
    fullname: Y Inoue
– volume: 5
  start-page: e9047
  year: 2010
  ident: 2675_CR21
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0009047
  contributor:
    fullname: E Lin
– ident: 2675_CR10
– volume: 12
  start-page: e0006230
  year: 2018
  ident: 2675_CR47
  publication-title: PLoS Negl Trop Dis.
  doi: 10.1371/journal.pntd.0006230
  contributor:
    fullname: J Recht
– volume: 13
  start-page: 488
  year: 2014
  ident: 2675_CR52
  publication-title: Malar J
  doi: 10.1186/1475-2875-13-488
  contributor:
    fullname: RJ Ingram
– volume: 56
  start-page: 295
  year: 1978
  ident: 2675_CR53
  publication-title: Bull World Health Organ
  contributor:
    fullname: T Tanahashi
– volume: 44
  start-page: 10
  year: 2016
  ident: 2675_CR16
  publication-title: Trop Med Health.
  doi: 10.1186/s41182-016-0008-7
  contributor:
    fullname: EL Matsumoto-Takahashi
– volume: 21
  start-page: 459
  year: 2006
  ident: 2675_CR37
  publication-title: Health Policy Plan
  doi: 10.1093/heapol/czl029
  contributor:
    fullname: S Vyas
– volume-title: Malaria diagnosis and the new treatment protocol, a training manual for health workers in Papua New Guinea
  year: 2010
  ident: 2675_CR34
  contributor:
    fullname: Divine Word University
– volume: 9
  start-page: 1219
  year: 2009
  ident: 2675_CR27
  publication-title: Rural Remote Health.
  contributor:
    fullname: HE Ashwell
– volume: 77
  start-page: 947
  year: 2007
  ident: 2675_CR30
  publication-title: Am J Trop Med Hyg.
  doi: 10.4269/ajtmh.2007.77.947
  contributor:
    fullname: J Marfurt
– volume: 9
  start-page: 308
  year: 2010
  ident: 2675_CR5
  publication-title: Malar J
  doi: 10.1186/1475-2875-9-308
  contributor:
    fullname: R Takeuchi
– volume: 41
  start-page: 871
  year: 2012
  ident: 2675_CR36
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dys037
  contributor:
    fullname: LD Howe
– volume: 27
  start-page: 4
  year: 2009
  ident: 2675_CR8
  publication-title: J Health Popul Nutr
  doi: 10.3329/jhpn.v27i1.3313
  contributor:
    fullname: N Khantikul
– volume: 48
  start-page: 141
  year: 2005
  ident: 2675_CR29
  publication-title: P N G Med J
  contributor:
    fullname: B Genton
– volume: 9
  start-page: 347
  year: 2010
  ident: 2675_CR14
  publication-title: Malar J
  doi: 10.1186/1475-2875-9-347
  contributor:
    fullname: V Phommanivong
– ident: 2675_CR11
– volume: 7
  start-page: 75
  year: 2008
  ident: 2675_CR18
  publication-title: Malar J
  doi: 10.1186/1475-2875-7-75
  contributor:
    fullname: LK Das
– volume-title: Standard treatment for common illness of adults in Papua New Guinea: a manual for nurses, community health workers, health extension officers and doctors
  year: 2003
  ident: 2675_CR33
  contributor:
    fullname: Papua New Guinea National Department of Health
– volume: 8
  start-page: 41
  year: 2009
  ident: 2675_CR20
  publication-title: Malar J
  doi: 10.1186/1475-2875-8-41
  contributor:
    fullname: I Mueller
– volume: 10
  start-page: 355
  year: 2011
  ident: 2675_CR38
  publication-title: Malar J
  doi: 10.1186/1475-2875-10-355
  contributor:
    fullname: EA Pereira
– volume: 8
  start-page: 290
  year: 2003
  ident: 2675_CR40
  publication-title: Trop Med Int Health.
  doi: 10.1046/j.1365-3156.2003.01030.x
  contributor:
    fullname: O Müller
– volume: 12
  start-page: 433
  year: 2013
  ident: 2675_CR24
  publication-title: Malar J
  doi: 10.1186/1475-2875-12-433
  contributor:
    fullname: J Pulford
– volume-title: Control and elimination of Plasmodium vivax: a technical brief
  year: 2015
  ident: 2675_CR1
  contributor:
    fullname: WHO
– ident: 2675_CR19
– volume: 14
  start-page: 778
  year: 2010
  ident: 2675_CR44
  publication-title: AIDS Behav
  doi: 10.1007/s10461-009-9533-2
  contributor:
    fullname: DM Tuller
– ident: 2675_CR25
– volume: 67
  start-page: e123
  year: 2014
  ident: 2675_CR43
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000000315
  contributor:
    fullname: LA Sowah
– volume: 7
  start-page: e40183
  year: 2012
  ident: 2675_CR48
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0040183
  contributor:
    fullname: TN Nissen
– volume: 9
  start-page: 85
  year: 2009
  ident: 2675_CR17
  publication-title: BMC Public Health.
  doi: 10.1186/1471-2458-9-85
  contributor:
    fullname: M Morrow
– volume: 49
  start-page: 248
  year: 2016
  ident: 2675_CR7
  publication-title: Rev Soc Bras Med Trop
  doi: 10.1590/0037-8682-0275-2015
  contributor:
    fullname: ED Almeida
– volume: 36
  start-page: 163
  year: 2008
  ident: 2675_CR45
  publication-title: Trop Med Health.
  doi: 10.2149/tmh.2008-13
  contributor:
    fullname: N Hung
– ident: 2675_CR12
– volume: 54
  start-page: 147
  year: 2011
  ident: 2675_CR26
  publication-title: PNG Med J.
  contributor:
    fullname: D O'Keefe
– volume: 1
  start-page: e121
  year: 2006
  ident: 2675_CR49
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0000121
  contributor:
    fullname: R Zachariah
– volume-title: National malaria treatment policy
  year: 2009
  ident: 2675_CR32
  contributor:
    fullname: Papua New Guinea National Department of Health
– volume-title: World malaria report
  year: 2017
  ident: 2675_CR2
  contributor:
    fullname: WHO
– volume: 82
  start-page: 1017
  year: 2010
  ident: 2675_CR22
  publication-title: Am J Trop Med Hyg.
  doi: 10.4269/ajtmh.2010.09-0521
  contributor:
    fullname: KP Grietens
– volume: 14
  start-page: 1
  year: 2015
  ident: 2675_CR41
  publication-title: Malar J
  doi: 10.1186/1475-2875-14-1
  contributor:
    fullname: MM Thandar
– volume: 16
  start-page: 141
  year: 2017
  ident: 2675_CR4
  publication-title: Malar J
  doi: 10.1186/s12936-017-1784-1
  contributor:
    fullname: K Thriemer
– volume: 8
  start-page: 118
  year: 2009
  ident: 2675_CR6
  publication-title: Malar J
  doi: 10.1186/1475-2875-8-118
  contributor:
    fullname: A Souares
– volume: 9
  start-page: 320
  year: 2010
  ident: 2675_CR42
  publication-title: Malar J
  doi: 10.1186/1475-2875-9-320
  contributor:
    fullname: A Getahun
– volume: 80
  start-page: 237
  year: 1947
  ident: 2675_CR50
  publication-title: J Infect Dis
  doi: 10.1093/infdis/80.3.237
  contributor:
    fullname: CM Whorton
– volume: 15
  start-page: 536
  year: 2016
  ident: 2675_CR23
  publication-title: Malar J
  doi: 10.1186/s12936-016-1588-8
  contributor:
    fullname: M Karyana
SSID ssj0017872
Score 2.2760553
Snippet To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment. Although in...
Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment....
BACKGROUNDTo control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage treatment....
Abstract Background To control and eventually eliminate vivax malaria, radical treatment with primaquine (PQ) is essential after completion of blood-stage...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 42
SubjectTerms Access
Analysis
Antimalarials
Blood
Case management
Child
Child health
Children
Childrens health
Continuity of patient care
Data collection
Dehydrogenases
Diagnosis
Drug therapy
Economics
Epidemiology
Glucose
Health facilities
Health service accessibility
Health services
Households
Human diseases
Malaria
Medical diagnosis
Medical treatment
Patient compliance
Patients
Policies
Primaquine
Principal components analysis
Regression analysis
Rural areas
Studies
Surveying
Therapeutic uses
Transportation
Tuberculosis
Vector-borne diseases
Vivax malaria
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA-lp0IpWm0drRJBEIShmXxNcqylaxGUHlroLeRjgr1Mt93dgzf_Df89_xLfm8wuO_TgxesmC0ne1y-T936PkA8dxGCuMq9TI-CCwr2sg0Yi11YnoVhWPGNx8rfv-vJGfr1Vt1utvjAnrNADl4M7TbBV39goAqYkShkSAPQ26ibIDOC-1JEzu75Mje8HoIZ8fMNsjD5dYFTDm7OtOSDkWk6i0EDW_9Qlb8Wkab7kVgCaPSMHI3KkZ2XFz8lO1x-S_fLZjZZqohekn5X-OdSPx94lip9a6bpo-8-v3wtaih9p9hEzY39SLDBfLijgVzpH9omHFWBPuslBp3c9fUR6Dnrl5ytPwTHSLzjFvyQ3s4vr88t6bKlQR4A2S3wANqzNLLEYlRUeL3y6zUpxk7gWIQRADNl0PkuNraoECxkglWfSR4OtYY7Ibn_fd68IZam1PNvEfLIgFQm4xnqjDPNI4pVMRT6tj9jNC3OGG24cRrsiDwfycCgPJyvyGYWwmYik18MPoApuVAX3L1WoyEcUoUPTBDlFP1YYwHqR5MqdKQN4FznkK3IymQkmFafDayVwo0kvHLh2IbnUAhb7fjOM_8Q0tb67X-EcIxUS1rOKHBed2WwJnKnRxjYVaSfaNNnzdKS_-zEQfoOPFLxVr__HIb0hexztAKvy2QnZXT6uureAq5bh3WBCfwFv8h-q
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fi9QwEB9070FBRM9_1VMiCIJQLk2TNH2SO7n1EDwO8eDeQto0ei_dve3ug29-Db-en8SZNq1XBF83Wbbd-febZOY3AG8ajMFCBZH6LMcERTiZVpqIXAvtc8WDEoGakz-f6dML-elSXcYDty6WVY4-sXfUflXTGfkhWlYuhdS5fL--TmlqFN2uxhEat2FPYKYgFrB3fHJ2_mW6R0B1FPEuMzP6sKPoRhl0mQpEyqmcRaOetP9f13wjNs3rJm8EouUDuB8RJDsaRP4QbjXtPtwZG4y7fbg3HMWxocPoEbTLYaYOc1EUjWd0_MrGRu7fP391bGiIZMHVVC37g1HT-bZjiGnZmhgprneIR9lUl86uWrYhyg527tY7x9BZso-0xT2Gi-XJ1w-naRyzkNYId7Z0KWx4Ebjnda3K3FESqIuglDBe6LyqKkQRwTQuSE3jq3JeBYRZjktXGxoX8wQW7aptngHjvihFKD13vpSVl4h1SmeU4Y6IvbxJ4N34d9v1wKZh-yzEaDvIxqJsLMnGygSOSSDTRiLC7j9Ybb7ZaFfWoyW4rKzziipWJf4o5m9FrbNKBsz9igTekjgtmSvKrHax6wCfl4iv7JEyiIGJVz6Bg9lONLN6vjwqhI1m3tm_SpnA62mZvkmla22z2tEeIxWR2PMEng76M70SOlijTZklUMw0a_bO85X26ntPAo5-MxeFev7_x3oBdwVpO_Xg8wNYbDe75iWiqG31KprKH3nzHCQ
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LaxRBEC5ivAgivh2N0oIgCKO9_Zqeg0gSXIOgeHAht6Z7ejoGZHazDzA3_4Z_L78kVfNYM5iL1-nanZmu93TVVwCvavTBQieRx4nEBEV4lQdDQK6FiVLzpEWi5uQvX83RTH0-1sc7MIy36jdwdW1qR_OkZsufb3-dnX9AhX_fKrw171bksygvLnOB8W-ubsBNQbhcVMmn_h4qoGy2h58KaTBR0P0h57V_MXJTLZr_vzb7itMaF1Re8VDTu3CnDy3ZficL92Cnbu7D7e67HOvajR5AM-0G7DDf86WOjL7FsqGr--L3nxXruiNZ8hWVzp4z6kBfrxgGuGxB8BRnGwxO2bZInZ02bEn4HeybX2w8Q8vJPhGJfwiz6cfvh0d5P3MhrzD2WdMJseVF4pFXlS6lp4zQFElrYaMwMoSAIUWytU_K0CwryUPCmMtz5StLs2MewW4zb-onwHgsSpHKyH0sVYgKA5_SW225J5SvaDN4M2yxW3TQGq5NSaxxHT8c8sMRP5zK4ICYsCUkVOz2wnx54nolcxHVwk_KSgYqX1V4U0zmispMgkqYCBYZvCYWOpIm5FPl-xYEfF5CwXL72mJATCDzGeyNKFHnqvHyIARuEFmHtl8qoYzEh325XaZfUh1bU883RGOVJkR7nsHjTma2r4TW1hpbTjIoRtI0eufxSnP6o0UERyMqRaGf_s-OPoNbguSd2vP5Huyul5v6OQZY6_CiVZtLfrIfnw
  priority: 102
  providerName: Scholars Portal
Title Factors associated with children's health facility visits for primaquine treatment in rural Papua New Guinea
URI https://www.ncbi.nlm.nih.gov/pubmed/30786891
https://www.proquest.com/docview/2193424634
https://search.proquest.com/docview/2184535580
https://pubmed.ncbi.nlm.nih.gov/PMC6383275
https://doaj.org/article/deada19c3b014144bd9667c61b4f4957
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJeimU0nfdposKhULBWVmWZPmYLNmGwoalNLA3oYfVLjTe7T4OvfVv9O_1l3TGjyWmt158sGQse76RZqSZbwh5V8EazGXkachycFC4FalTSORaqJBLFiWPmJw8u1ZXN-LTQi6OiOxzYZqgfe-WZ_X327N6-a2JrVzf-nEfJzaezyaAmZwXcnxMjgGgvYveHR0AAnl3fJlpNd7igoZOc5lyMI5TLMQDuNZKl9lgLWoo-_-dmO-sTMOoyTvL0PQRedjZj_S8HedjclTVT8iDdvONtjlFT0k9bavoUNv9_CpQ3HClfer2n1-_t7RNgaTReoyP_UkxzXy3pWDF0jVyUPzYgwVKD5HodFnTDZJ00Lld7y2F6ZF-xC72GbmZXn6ZXKVdYYXUg4Gzw2NgzYrIAvNelrlFt08VUUquA1e5cw7shqgrG4XCglU5cxEMK8uE9RoLxDwnJ_Wqrl4SykJR8lgGZkMpXBBg3ZRWS80sUnkFnZAP_S8265Y_wzR-h1amFY0B0RgUjREJuUAhHDoi9XVzY7X5ajoAmADYt1npc4cxqgJeCh5b4VXmRARvr0jIexShQQUFOXnb5RnAeJHqypxLDVYvMskn5HTQExTLD5t7EJhOsbcGJvhccKFyGOzbQzM-icFqdbXaYx8tJNLWs4S8aDFz-KQeegkpBmgafPOwBbSgof3uUP_qv598Te5z1ANMyGen5GS32VdvwKTauREo0qKAq55kI3Lv4vJ6_nnUbE_AdSb0qFGxvycGJTI
link.rule.ids 230,315,730,783,787,867,888,2109,12070,12237,21402,24332,27938,27939,31733,31734,33280,33281,33758,33759,43324,43593,43819,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwED_B9jCkCcH4FxhgJCQkpGiOYzvOE9rQSoGtmtAm7c1y4hj2knZN-7A3vgZfj0_CXeOWRUi81q6a9P79zr77HcDbBmOwUEGkPssxQRFOppUmItdC-1zxoESg5uTTiR5fyC-X6jIeuHWxrHLtE1eO2k9rOiM_QMvKpZA6lx9m1ylNjaLb1ThC4y5sE1UVavX20fHk7NvmHgHVUcS7zMzog46iG2XQZSoQKadyEI1WpP3_uuZbsWlYN3krEI0ewP2IINlhL_KHcKdp92Bn3WDc7cFufxTH-g6jR9CO-pk6zEVRNJ7R8StbN3L__vmrY31DJAuupmrZG0ZN54uOIaZlM2KkuF4iHmWbunR21bI5UXawMzdbOobOkn2iLe4xXIyOzz-O0zhmIa0R7izoUtjwInDP61qVuaMkUBdBKWG80HlVVYgigmlckJrGV-W8CgizHJeuNjQu5glstdO2eQaM-6IUofTc-VJWXiLWKZ1Rhjsi9vImgffrv9vOejYNu8pCjLa9bCzKxpJsrEzgiASy2UhE2KsPpvPvNtqV9WgJLivrvKKKVYk_ivlbUeuskgFzvyKBdyROS-aKMqtd7DrA5yXiK3uoDGJg4pVPYH-wE82sHi6vFcJGM-_sX6VM4M1mmb5JpWttM13SHiMVkdjzBJ72-rN5JXSwRpsyS6AYaNbgnYcr7dWPFQk4-s1cFOr5_x_rNeyMz09P7MnnydcXcE-Q5lM_Pt-HrcV82bxERLWoXkWz-QMfIh8e
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSAip4v0IFDASEhJSdr2O7TjHUljKo9UeqFRxsfyIYVWaXfZxgBN_g7_HL2Emj9UGbr3GjhJnvvHMxDPfEPK8BBvMZeRpGGUQoHArUqeQyDVXIZMsSh6xOPnoWB2eiPen8nSr1VedtO_ddFB9Ox9U0691buX83A-7PLHh5OgAMJPxXA7nIQ4vkyugs0x3gXp7gAA45O0h5kir4RLNGobORcrBRU6xHQ-gWytdjHoWqSbu_3973rJP_dzJLWM0vkE-d8toclDOBuuVG_if_zA8XmidN8n11kWl-82UW-RSWd0mu83_PdqULd0h1bhp1ENtK98yUPynS7vq8D-_fi9pU2VJo_WYgvuDYiX7aknBUaZzpLn4vgYnl26S3em0ogvkAaETO19bCjswfYtT7F1yMn7z6eAwbXs3pB58qBWeNGuWRxaY97LILEaWKo9Sch24ypxz4JpEXdooFPbEypiL4LtZJqzX2IPmHtmpZlX5gFAW8oLHIjAbCuGCAAeqsFpqZpEtLOiEvOzkZ-YNRYepQxutTCN3A3I3KHcjEvIKJbyZiOza9YXZ4otpv70JoF52VPjMYRqsgIdCUJh7NXIiQkCZJ-QF4sPgHgAg8LYtZYD3RTYtsy81ONZIVp-Qvd5M0F3fH-4QZtq9Y2nAhmSCC5XByz7bDOOdmA9XlbM1ztFCIjM-S8j9BpCbJXW4Tkjeg2pvzf0RAGDNLN4C7uGF73xKrk5ej83Hd8cfHpFrHPUNy__ZHtlZLdblY3DgVu5Jrap_AV6dRI8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+associated+with+children%E2%80%99s+health+facility+visits+for+primaquine+treatment+in+rural+Papua+New+Guinea&rft.jtitle=Malaria+journal&rft.au=Yoshii%2C+Akiko&rft.au=Sekihara%2C+Makoto&rft.au=Furusawa%2C+Takuro&rft.au=Hombhanje%2C+Francis&rft.date=2019-02-20&rft.issn=1475-2875&rft.eissn=1475-2875&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1186%2Fs12936-019-2675-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12936_019_2675_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2875&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2875&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2875&client=summon